Erik C von Rosenvinge

发表

Improving High-resolution Impedance Manometry Using Novel Viscous and Super-viscous Substrates in the Supine and Upright Positions: A Pilot Study

D. Castell, Uni Wong, E. Person, 2018, Journal of neurogastroenterology and motility.

Identification, immunogenicity, and cross-reactivity of type IV pilin and pilin-like proteins from Clostridium difficile.

Grace A Maldarelli, Erik C von Rosenvinge, M. Donnenberg, 2014, Pathogens and disease.

Multiple endoscopic biopsies in research subjects: safety results from a National Institutes of Health series.

P. Mannon, C. Groden, Erik C von Rosenvinge, 2009, Gastrointestinal endoscopy.

Structure of Clostridium difficile PilJ Exhibits Unprecedented Divergence from Known Type IV Pilins*

Grace A Maldarelli, Kurt H Piepenbrink, G. Armstrong, 2013, The Journal of Biological Chemistry.

Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity

K. Garey, T. Savidge, H. Feng, 2017, Clinical and Vaccine Immunology.

Improving global digestive health: the gastroenterologists' role.

Erik C von Rosenvinge, K. Chudy-Onwugaje, 2020, The Lancet Gastroenterology and Hepatology.

Type IV pili promote early biofilm formation by Clostridium difficile.

Grace A Maldarelli, Alison J. Scott, E. Sundberg, 2016, Pathogens and disease.

Bacterial Baptism: Scientific, Medical, and Regulatory Issues Raised by Vaginal Seeding of C-Section-Born Babies

D. Hoffmann, Erik C von Rosenvinge, M. Dominguez-Bello, 2019, Journal of Law, Medicine & Ethics.

Gastrointestinal peptides and regulation of gastric acid secretion

Erik C von Rosenvinge, J. Raufman, 2010, Current opinion in endocrinology, diabetes, and obesity.

Identification of Toxemia in Patients with Clostridium difficile Infection

D. Aronoff, K. Garey, T. Savidge, 2015, PloS one.

Muscarinic Receptor Signaling in Colon Cancer

Erik C von Rosenvinge, J. Raufman, 2011, Cancers.

Chronic granulomatous disease.

S. Holland, Erik C von Rosenvinge, Thomas O'Donnell, 2010, Inflammatory bowel diseases.

Pseudomembranous colitis: Not always Clostridium difficile

Erik C von Rosenvinge, N. Urrunaga, D. Tang, 2016, Cleveland Clinic Journal of Medicine.

Bedside to bench: role of muscarinic receptor activation in ultrarapid growth of colorectal cancer in a patient with pheochromocytoma.

C. Drachenberg, Erik C von Rosenvinge, J. Raufman, 2013, Mayo Clinic proceedings.

A problematic polyp.

Erik C von Rosenvinge, B. Curtin, 2013, Gastroenterology.

A proposed definition of microbiota transplantation for regulatory purposes

J. Ravel, D. Hoffmann, Erik C von Rosenvinge, 2017, Gut microbes.

Pseudomembranous colitis.

Erik C von Rosenvinge, N. Urrunaga, Priya D. Farooq, 2015, Disease-a-month : DM.

Microbial biofilms and gastrointestinal diseases.

G. Macfarlane, S. Macfarlane, Erik C von Rosenvinge, 2013, Pathogens and disease.

Recurrent pneumatosis intestinalis in a patient with dermatomyositis

J. Mikdashi, Erik C von Rosenvinge, Yousef Zarbalian, 2013, BMJ Case Reports.

Primary sclerosing cholangitis and pancreatic cancer: A retrospective cohort study of United States veterans

Erik C von Rosenvinge, B. Sagvand, Madeline Alizadeh, 2023, Frontiers in Gastroenterology.

Benefit of N-Acetylcysteine in Postoperative Hepatic Dysfunction: Case Report and Review of Literature

Erik C von Rosenvinge, H. Akbar, P. John, 2019, Case reports in hepatology.

Microbiota Dynamics in Patients Treated with Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection

Shashank Garg, Yang Song, W. F. Fricke, 2013, PloS one.

Pseudomembranous Colitis: Not Always Caused by Clostridium difficile

Erik C von Rosenvinge, G. Xie, Leyla J. Ghazi, 2014, Case reports in medicine.

Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection.

J. Bartlett, W. F. Fricke, Erik C von Rosenvinge, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

When to leave a stone unturned …

S. Holland, Erik C von Rosenvinge, C. Koh, 2010, Gut.

Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.

Grant D. Huang, Robert H. Lee, W. Chey, 2019, The New England journal of medicine.

Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia

Erik C von Rosenvinge, C. Chu, Kamini Shah, 2017, World journal of clinical oncology.

Acute Hepatocellular Drug-Induced Liver Injury From Bupropion and Doxycycline

Erik C von Rosenvinge, C. Koh, W. Twaddell, 2015, ACG case reports journal.

Unusually late-onset mycophenolate mofetil-related colitis.

Erik C von Rosenvinge, V. Rachakonda, B. Curtin, 2014, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Application of Broad-Spectrum, Sequence-Based Pathogen Identification in an Urban Population

Frances S. Ligler, Kevin L. Russell, Baochuan Lin, 2007, PloS one.

Improving regulation of microbiota transplants

J. Ravel, D. Hoffmann, Erik C von Rosenvinge, 2017, Science.

Structural and evolutionary analyses show unique stabilization strategies in the type IV pili of Clostridium difficile.

Grace A Maldarelli, Kurt H Piepenbrink, G. Armstrong, 2015, Structure.

Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota

W. F. Fricke, J. White, Erik C von Rosenvinge, 2013, The ISME Journal.

Gastric masses in multiple endocrine neoplasia type I-associated Zollinger-Ellison syndrome.

Erik C von Rosenvinge, S. Wank, Ramona M. Lim, 2009, Gastroenterology.

Pseudomembranous colitis.

Erik C von Rosenvinge, N. Urrunaga, Priya D. Farooq, 2015, Disease-a-month : DM.